Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Wakunaga Pharmaceutical To Establish U.S. Factory To Produce Generics

This article was originally published in PharmAsia News

Executive Summary

Osaka-based Wakunaga Pharmaceutical announced April 30 that it will spend ¥1.5 billion to build a factory in California to produce OTC drugs. Wakunaga's goal is to establish OTC production facilities in Japan, the U.S. and Europe. The construction will start in July and is estimated to be completed in November 2011. Wakunaga plans to produce over 100 products in the new facility. (Click here for more - Japanese language)



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts